Sunshine Biopharma Inc. SBFM stock fell in Tuesday premarket trading, likely pressured by dilution concerns after the company announced the pricing of a $6 million public offering late Monday. The ...

Pharmaceutical stocks can be excellent defensive investments during times of economic uncertainty, and many pharma stocks are ...

(RTTNews) - Risk runs high, but so does the upside. Biotech investing thrives on bold bets and breakthrough data. On October 30, 2025, a wave of clinical-stage and commercial biopharma stocks surged ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Ardelyx ARDX is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has ...

Bank of America downgraded four U.S. biopharmaceutical companies, lowering ratings on Alkermes, Amphastar Pharmaceuticals and Biohaven to Underperform, while cutting Liquidia to Neutral, citing a ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella’s inaugural ...

ESTERO, FL / ACCESS Newswire / January 14, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), a biopharmaceutical company developing multi-faceted patent-pending drug ...

MannKind Corporation operates as a biopharmaceutical company specializing in respiratory-delivered treatments, with Afrezza, an inhaled insulin product, serving as its primary revenue generator for ...

Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.